A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma

MLA

Raffaella Iurlaro, et al. “A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.” Molecular Cancer Therapeutics, vol. 21, no. 10, Mar. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....331034627a80c0bd2fc3ebdbdf1c2aaf&authtype=sso&custid=ns315887.

APA

Raffaella Iurlaro, Inja Waldhauer, Ester Planas-Rigol, Ester Bonfill-Teixidor, Alexandra Arias, Valeria Nicolini, Anne Freimoser-Grundschober, Isabel Cuartas, Alba Martínez-Moreno, Francisco Martínez-Ricarte, Esteban Cordero, Marta Cicuendez, Simona Casalino, Xavier Guardia-Reyes, Linda Fahrni, Thomas Pöschinger, Virginie Steinhart, Marine Richard, Stefanie Briner, … Joan Seoane. (2022). A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma. Molecular Cancer Therapeutics, 21(10).

Chicago

Raffaella Iurlaro, Inja Waldhauer, Ester Planas-Rigol, Ester Bonfill-Teixidor, Alexandra Arias, Valeria Nicolini, Anne Freimoser-Grundschober, et al. 2022. “A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.” Molecular Cancer Therapeutics 21 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....331034627a80c0bd2fc3ebdbdf1c2aaf&authtype=sso&custid=ns315887.